Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 117 entries
Sorted by: Best Match Show Resources per page
Suppression of decoherence in fast-atom diffraction at surfaces.

Physical review letters

Aigner F, Simonović N, Solleder B, Wirtz L, Burgdörfer J.
PMID: 19113705
Phys Rev Lett. 2008 Dec 19;101(25):253201. doi: 10.1103/PhysRevLett.101.253201. Epub 2008 Dec 17.

Scattering of fast neutral atoms with keV kinetic energies at alkali-halide surfaces under grazing angles displays intriguing diffraction patterns. The surprisingly strong persistence of quantum coherence despite the impulsive interaction with an environment at solid state density and elevated...

Cite
Aigner F, Simonović N, Solleder B, et al. Suppression of decoherence in fast-atom diffraction at surfaces. Phys Rev Lett. 2008;101(25):253201doi: 10.1103/PhysRevLett.101.253201.
Aigner, F., Simonović, N., Solleder, B., Wirtz, L., & Burgdörfer, J. (2008). Suppression of decoherence in fast-atom diffraction at surfaces. Physical review letters, 101(25), 253201. https://doi.org/10.1103/PhysRevLett.101.253201
Aigner, F, et al. "Suppression of decoherence in fast-atom diffraction at surfaces." Physical review letters vol. 101,25 (2008): 253201. doi: https://doi.org/10.1103/PhysRevLett.101.253201
Aigner F, Simonović N, Solleder B, Wirtz L, Burgdörfer J. Suppression of decoherence in fast-atom diffraction at surfaces. Phys Rev Lett. 2008 Dec 19;101(25):253201. doi: 10.1103/PhysRevLett.101.253201. Epub 2008 Dec 17. PMID: 19113705.
Copy Download .nbib Format: NLM
Non-invasive diagnostic imaging of hepatocellular carcinoma: targeting cellular characterization?.

Journal of hepatology

Luciani A, Baranes L, Decaens T, Pigneur F, Laurent A, Nhieu JT, Rahmouni A.
PMID: 21334409
J Hepatol. 2011 Jul;55(1):224-6. doi: 10.1016/j.jhep.2011.01.026. Epub 2011 Feb 18.

No abstract available.

Cite
Luciani A, Baranes L, Decaens T, et al. Non-invasive diagnostic imaging of hepatocellular carcinoma: targeting cellular characterization?. J Hepatol. 2011;55(1):224-6doi: 10.1016/j.jhep.2011.01.026.
Luciani, A., Baranes, L., Decaens, T., Pigneur, F., Laurent, A., Nhieu, J. T., & Rahmouni, A. (2011). Non-invasive diagnostic imaging of hepatocellular carcinoma: targeting cellular characterization?. Journal of hepatology, 55(1), 224-6. https://doi.org/10.1016/j.jhep.2011.01.026
Luciani, Alain, et al. "Non-invasive diagnostic imaging of hepatocellular carcinoma: targeting cellular characterization?." Journal of hepatology vol. 55,1 (2011): 224-6. doi: https://doi.org/10.1016/j.jhep.2011.01.026
Luciani A, Baranes L, Decaens T, Pigneur F, Laurent A, Nhieu JT, Rahmouni A. Non-invasive diagnostic imaging of hepatocellular carcinoma: targeting cellular characterization?. J Hepatol. 2011 Jul;55(1):224-6. doi: 10.1016/j.jhep.2011.01.026. Epub 2011 Feb 18. PMID: 21334409.
Copy Download .nbib Format: NLM
Liver magnetic resonance diffusion weighted imaging: 2011 update.

Clinics and research in hepatology and gastroenterology

Chiaradia M, Baranes L, Pigneur F, Djabbari M, Zegai B, Brugières P, Zerbib P, Decaens T, Deux JF, Kobeiter H, Rahmouni A, Luciani A.
PMID: 21700529
Clin Res Hepatol Gastroenterol. 2011 Sep;35(8):539-48. doi: 10.1016/j.clinre.2011.05.001. Epub 2011 Jun 22.

Diffusion-Weighted-Imaging (DWI) assesses proton motion on a cellular scale. Owing to recent instrumentation developments, diffusion sequences are now routinely used for liver imaging. This review will go through the physical principles that underlie this technique, and then highlight up-to-date...

Cite
Chiaradia M, Baranes L, Pigneur F, et al. Liver magnetic resonance diffusion weighted imaging: 2011 update. Clin Res Hepatol Gastroenterol. 2011;35(8):539-48doi: 10.1016/j.clinre.2011.05.001.
Chiaradia, M., Baranes, L., Pigneur, F., Djabbari, M., Zegai, B., Brugières, P., Zerbib, P., Decaens, T., Deux, J. F., Kobeiter, H., Rahmouni, A., & Luciani, A. (2011). Liver magnetic resonance diffusion weighted imaging: 2011 update. Clinics and research in hepatology and gastroenterology, 35(8), 539-48. https://doi.org/10.1016/j.clinre.2011.05.001
Chiaradia, Mélanie, et al. "Liver magnetic resonance diffusion weighted imaging: 2011 update." Clinics and research in hepatology and gastroenterology vol. 35,8 (2011): 539-48. doi: https://doi.org/10.1016/j.clinre.2011.05.001
Chiaradia M, Baranes L, Pigneur F, Djabbari M, Zegai B, Brugières P, Zerbib P, Decaens T, Deux JF, Kobeiter H, Rahmouni A, Luciani A. Liver magnetic resonance diffusion weighted imaging: 2011 update. Clin Res Hepatol Gastroenterol. 2011 Sep;35(8):539-48. doi: 10.1016/j.clinre.2011.05.001. Epub 2011 Jun 22. PMID: 21700529.
Copy Download .nbib Format: NLM
Correction to: Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful?.

Abdominal radiology (New York)

Roux M, Pigneur F, Baranes L, Calderaro J, Chiaradia M, Decaens T, Kastahian S, Charles-Nelson A, Tselikas L, Costentin C, Laurent A, Azoulay D, Mallat A, Rahmouni A, Luciani A.
PMID: 29230554
Abdom Radiol (NY). 2018 Aug;43(8):2212. doi: 10.1007/s00261-017-1423-x.

The original version of this article unfortunately contained a mistake. There was an error in the last sentence of the summary and the last sentence of the discussion. It should read as "On HBP, all FNH appeared hyper- or...

Cite
Roux M, Pigneur F, Baranes L, et al. Correction to: Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful?. Abdom Radiol (NY). 2018;43(8):2212doi: 10.1007/s00261-017-1423-x.
Roux, M., Pigneur, F., Baranes, L., Calderaro, J., Chiaradia, M., Decaens, T., Kastahian, S., Charles-Nelson, A., Tselikas, L., Costentin, C., Laurent, A., Azoulay, D., Mallat, A., Rahmouni, A., & Luciani, A. (2018). Correction to: Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful?. Abdominal radiology (New York), 43(8), 2212. https://doi.org/10.1007/s00261-017-1423-x
Roux, Marion, et al. "Correction to: Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful?." Abdominal radiology (New York) vol. 43,8 (2018): 2212. doi: https://doi.org/10.1007/s00261-017-1423-x
Roux M, Pigneur F, Baranes L, Calderaro J, Chiaradia M, Decaens T, Kastahian S, Charles-Nelson A, Tselikas L, Costentin C, Laurent A, Azoulay D, Mallat A, Rahmouni A, Luciani A. Correction to: Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful?. Abdom Radiol (NY). 2018 Aug;43(8):2212. doi: 10.1007/s00261-017-1423-x. PMID: 29230554.
Copy Download .nbib Format: NLM
Brunn's Cyst Inducing Persistent Lower Urinary Tract Symptoms in a Young Man: A Case Report.

Journal of endourology case reports

Lindner AK, Schachtner G, Aigner F, Biggel S, Horninger W, Pichler R.
PMID: 32775656
J Endourol Case Rep. 2019 Dec 02;5(4):171-173. doi: 10.1089/cren.2019.0065. eCollection 2019.

No abstract available.

Cite
Lindner AK, Schachtner G, Aigner F, et al. Brunn's Cyst Inducing Persistent Lower Urinary Tract Symptoms in a Young Man: A Case Report. J Endourol Case Rep. 2019;5(4):171-173doi: 10.1089/cren.2019.0065.
Lindner, A. K., Schachtner, G., Aigner, F., Biggel, S., Horninger, W., & Pichler, R. (2019). Brunn's Cyst Inducing Persistent Lower Urinary Tract Symptoms in a Young Man: A Case Report. Journal of endourology case reports, 5(4), 171-173. https://doi.org/10.1089/cren.2019.0065
Lindner, Andrea Katharina, et al. "Brunn's Cyst Inducing Persistent Lower Urinary Tract Symptoms in a Young Man: A Case Report." Journal of endourology case reports vol. 5,4 (2019): 171-173. doi: https://doi.org/10.1089/cren.2019.0065
Lindner AK, Schachtner G, Aigner F, Biggel S, Horninger W, Pichler R. Brunn's Cyst Inducing Persistent Lower Urinary Tract Symptoms in a Young Man: A Case Report. J Endourol Case Rep. 2019 Dec 02;5(4):171-173. doi: 10.1089/cren.2019.0065. eCollection 2019. PMID: 32775656; PMCID: PMC7383459.
Copy Download .nbib Format: NLM
Wire-Based Additive Manufacturing of Ti-6Al-4V Using Electron Beam Technique.

Materials (Basel, Switzerland)

Pixner F, Warchomicka F, Peter P, Steuwer A, Colliander MH, Pederson R, Enzinger N.
PMID: 32722303
Materials (Basel). 2020 Jul 24;13(15). doi: 10.3390/ma13153310.

Electron beam freeform fabrication is a wire feed direct energy deposition additive manufacturing process, where the vacuum condition ensures excellent shielding against the atmosphere and enables processing of highly reactive materials. In this work, this technique is applied for...

Cite
Pixner F, Warchomicka F, Peter P, et al. Wire-Based Additive Manufacturing of Ti-6Al-4V Using Electron Beam Technique. Materials (Basel). 2020;13(15)doi: 10.3390/ma13153310.
Pixner, F., Warchomicka, F., Peter, P., Steuwer, A., Colliander, M. H., Pederson, R., & Enzinger, N. (2020). Wire-Based Additive Manufacturing of Ti-6Al-4V Using Electron Beam Technique. Materials (Basel, Switzerland), 13(15), . https://doi.org/10.3390/ma13153310
Pixner, Florian, et al. "Wire-Based Additive Manufacturing of Ti-6Al-4V Using Electron Beam Technique." Materials (Basel, Switzerland) vol. 13,15 (2020). doi: https://doi.org/10.3390/ma13153310
Pixner F, Warchomicka F, Peter P, Steuwer A, Colliander MH, Pederson R, Enzinger N. Wire-Based Additive Manufacturing of Ti-6Al-4V Using Electron Beam Technique. Materials (Basel). 2020 Jul 24;13(15). doi: 10.3390/ma13153310. PMID: 32722303; PMCID: PMC7435555.
Copy Download .nbib Format: NLM
Is sarcopenia a missed factor in the management of patients with metastatic breast cancer?.

Breast (Edinburgh, Scotland)

Deluche E, Lachatre D, Di Palma M, Simon H, Tissot V, Vansteene D, Meingan P, Mohebi A, Lenczner G, Pigneur F, Goldwasser F, Raynard B.
PMID: 34923226
Breast. 2021 Dec 15;61:84-90. doi: 10.1016/j.breast.2021.12.014. Epub 2021 Dec 15.

BACKGROUND: Sarcopenia has emerged as an important parameter to predict outcomes and treatment toxicity. However, limited data are available to assess sarcopenia prevalence in metastatic breast cancer and to evaluate its management.METHODS: The SCAN study was a cross-sectional multicenter...

Cite
Deluche E, Lachatre D, Di Palma M, et al. Is sarcopenia a missed factor in the management of patients with metastatic breast cancer?. Breast. 2021;61:84-90doi: 10.1016/j.breast.2021.12.014.
Deluche, E., Lachatre, D., Di Palma, M., Simon, H., Tissot, V., Vansteene, D., Meingan, P., Mohebi, A., Lenczner, G., Pigneur, F., Goldwasser, F., Raynard, B. (2021). Is sarcopenia a missed factor in the management of patients with metastatic breast cancer?. Breast (Edinburgh, Scotland), 6184-90. https://doi.org/10.1016/j.breast.2021.12.014
Deluche, Elise, et al. "Is sarcopenia a missed factor in the management of patients with metastatic breast cancer?." Breast (Edinburgh, Scotland) vol. 61 (2021): 84-90. doi: https://doi.org/10.1016/j.breast.2021.12.014
Deluche E, Lachatre D, Di Palma M, Simon H, Tissot V, Vansteene D, Meingan P, Mohebi A, Lenczner G, Pigneur F, Goldwasser F, Raynard B. Is sarcopenia a missed factor in the management of patients with metastatic breast cancer?. Breast. 2021 Dec 15;61:84-90. doi: 10.1016/j.breast.2021.12.014. Epub 2021 Dec 15. PMID: 34923226; PMCID: PMC8693346.
Copy Download .nbib Format: NLM
Synthetic polypeptide crotamine: characterization as a myotoxin and as a target of combinatorial peptides.

Journal of molecular medicine (Berlin, Germany)

Pompeia C, Frare EO, Peigneur S, Tytgat J, da Silva ÁP, de Oliveira EB, Pereira A, Kerkis I, Kolonin MG.
PMID: 34643765
J Mol Med (Berl). 2021 Oct 13; doi: 10.1007/s00109-021-02140-9. Epub 2021 Oct 13.

Crotamine is a rattlesnake-derived toxin that causes fast-twitch muscle paralysis. As a cell-penetrating polypeptide, crotamine has been investigated as an experimental anti-cancer and immunotherapeutic agent. We hypothesized that molecules targeting crotamine could be designed to study its function and...

Cite
Pompeia C, Frare EO, Peigneur S, et al. Synthetic polypeptide crotamine: characterization as a myotoxin and as a target of combinatorial peptides. J Mol Med (Berl). 2021;doi: 10.1007/s00109-021-02140-9.
Pompeia, C., Frare, E. O., Peigneur, S., Tytgat, J., da Silva, �. �. P., de Oliveira, E. B., Pereira, A., Kerkis, I., & Kolonin, M. G. (2021). Synthetic polypeptide crotamine: characterization as a myotoxin and as a target of combinatorial peptides. Journal of molecular medicine (Berlin, Germany), . https://doi.org/10.1007/s00109-021-02140-9
Pompeia, Celine, et al. "Synthetic polypeptide crotamine: characterization as a myotoxin and as a target of combinatorial peptides." Journal of molecular medicine (Berlin, Germany) vol. (2021). doi: https://doi.org/10.1007/s00109-021-02140-9
Pompeia C, Frare EO, Peigneur S, Tytgat J, da Silva ÁP, de Oliveira EB, Pereira A, Kerkis I, Kolonin MG. Synthetic polypeptide crotamine: characterization as a myotoxin and as a target of combinatorial peptides. J Mol Med (Berl). 2021 Oct 13; doi: 10.1007/s00109-021-02140-9. Epub 2021 Oct 13. PMID: 34643765.
Copy Download .nbib Format: NLM
Identification, Synthesis, Conformation and Activity of an Insulin-like Peptide from a Sea Anemone.

Biomolecules

Mitchell ML, Hossain MA, Lin F, Pinheiro-Junior EL, Peigneur S, Wai DCC, Delaine C, Blyth AJ, Forbes BE, Tytgat J, Wade JD, Norton RS.
PMID: 34944429
Biomolecules. 2021 Nov 29;11(12). doi: 10.3390/biom11121785.

The role of insulin and insulin-like peptides (ILPs) in vertebrate animals is well studied. Numerous ILPs are also found in invertebrates, although there is uncertainty as to the function and role of many of these peptides. We have identified...

Cite
Mitchell ML, Hossain MA, Lin F, et al. Identification, Synthesis, Conformation and Activity of an Insulin-like Peptide from a Sea Anemone. Biomolecules. 2021;11(12)doi: 10.3390/biom11121785.
Mitchell, M. L., Hossain, M. A., Lin, F., Pinheiro-Junior, E. L., Peigneur, S., Wai, D. C. C., Delaine, C., Blyth, A. J., Forbes, B. E., Tytgat, J., Wade, J. D., & Norton, R. S. (2021). Identification, Synthesis, Conformation and Activity of an Insulin-like Peptide from a Sea Anemone. Biomolecules, 11(12), . https://doi.org/10.3390/biom11121785
Mitchell, Michela L, et al. "Identification, Synthesis, Conformation and Activity of an Insulin-like Peptide from a Sea Anemone." Biomolecules vol. 11,12 (2021). doi: https://doi.org/10.3390/biom11121785
Mitchell ML, Hossain MA, Lin F, Pinheiro-Junior EL, Peigneur S, Wai DCC, Delaine C, Blyth AJ, Forbes BE, Tytgat J, Wade JD, Norton RS. Identification, Synthesis, Conformation and Activity of an Insulin-like Peptide from a Sea Anemone. Biomolecules. 2021 Nov 29;11(12). doi: 10.3390/biom11121785. PMID: 34944429.
Copy Download .nbib Format: NLM
Increased Use of Anti-Tumor Necrosis Factor Following the Implementation of the ECCO-ESPGHAN Guidelines and its Impact on the Outcome of Pediatric Crohn's Disease: A Retrospective Single-Center Study.

Journal of pediatric gastroenterology and nutrition

D'Arcangelo G, Abi Nader E, Charbit-Henrion F, Talbotec C, Goulet O, Ruemmele FM, Pigneur B.
PMID: 34962501
J Pediatr Gastroenterol Nutr. 2022 Jan 01;74(1):79-84. doi: 10.1097/MPG.0000000000003301.

OBJECTIVES: The first ECCO-ESPGHAN guidelines for the medical management of pediatric Crohn disease (CD) were published in 2014. Whether their implementation, and the consequent increased use of an upfront anti-tumor necrosis factor therapy, have changed the course of the...

Cite
D'Arcangelo G, Abi Nader E, Charbit-Henrion F, et al. Increased Use of Anti-Tumor Necrosis Factor Following the Implementation of the ECCO-ESPGHAN Guidelines and its Impact on the Outcome of Pediatric Crohn's Disease: A Retrospective Single-Center Study. J Pediatr Gastroenterol Nutr. 2022;74(1):79-84doi: 10.1097/MPG.0000000000003301.
D'Arcangelo, G., Abi Nader, E., Charbit-Henrion, F., Talbotec, C., Goulet, O., Ruemmele, F. M., & Pigneur, B. (2022). Increased Use of Anti-Tumor Necrosis Factor Following the Implementation of the ECCO-ESPGHAN Guidelines and its Impact on the Outcome of Pediatric Crohn's Disease: A Retrospective Single-Center Study. Journal of pediatric gastroenterology and nutrition, 74(1), 79-84. https://doi.org/10.1097/MPG.0000000000003301
D'Arcangelo, Giulia, et al. "Increased Use of Anti-Tumor Necrosis Factor Following the Implementation of the ECCO-ESPGHAN Guidelines and its Impact on the Outcome of Pediatric Crohn's Disease: A Retrospective Single-Center Study." Journal of pediatric gastroenterology and nutrition vol. 74,1 (2022): 79-84. doi: https://doi.org/10.1097/MPG.0000000000003301
D'Arcangelo G, Abi Nader E, Charbit-Henrion F, Talbotec C, Goulet O, Ruemmele FM, Pigneur B. Increased Use of Anti-Tumor Necrosis Factor Following the Implementation of the ECCO-ESPGHAN Guidelines and its Impact on the Outcome of Pediatric Crohn's Disease: A Retrospective Single-Center Study. J Pediatr Gastroenterol Nutr. 2022 Jan 01;74(1):79-84. doi: 10.1097/MPG.0000000000003301. PMID: 34962501.
Copy Download .nbib Format: NLM
Human Three-Finger Protein Lypd6 Is a Negative Modulator of the Cholinergic System in the Brain.

Frontiers in cell and developmental biology

Kulbatskii D, Shenkarev Z, Bychkov M, Loktyushov E, Shulepko M, Koshelev S, Povarov I, Popov A, Peigneur S, Chugunov A, Kozlov S, Sharonova I, Efremov R, Skrebitsky V, Tytgat J, Kirpichnikov M, Lyukmanova E.
PMID: 34631692
Front Cell Dev Biol. 2021 Sep 21;9:662227. doi: 10.3389/fcell.2021.662227. eCollection 2021.

Lypd6 is a GPI-tethered protein from the Ly-6/uPAR family expressed in the brain. Lypd6 enhances the Wnt/β-catenin signaling, although its action on nicotinic acetylcholine receptors (nAChRs) have been also proposed. To investigate a cholinergic activity of Lypd6, we studied...

Cite
Kulbatskii D, Shenkarev Z, Bychkov M, et al. Human Three-Finger Protein Lypd6 Is a Negative Modulator of the Cholinergic System in the Brain. Front Cell Dev Biol. 2021;9:662227doi: 10.3389/fcell.2021.662227.
Kulbatskii, D., Shenkarev, Z., Bychkov, M., Loktyushov, E., Shulepko, M., Koshelev, S., Povarov, I., Popov, A., Peigneur, S., Chugunov, A., Kozlov, S., Sharonova, I., Efremov, R., Skrebitsky, V., Tytgat, J., Kirpichnikov, M., & Lyukmanova, E. (2021). Human Three-Finger Protein Lypd6 Is a Negative Modulator of the Cholinergic System in the Brain. Frontiers in cell and developmental biology, 9662227. https://doi.org/10.3389/fcell.2021.662227
Kulbatskii, Dmitrii, et al. "Human Three-Finger Protein Lypd6 Is a Negative Modulator of the Cholinergic System in the Brain." Frontiers in cell and developmental biology vol. 9 (2021): 662227. doi: https://doi.org/10.3389/fcell.2021.662227
Kulbatskii D, Shenkarev Z, Bychkov M, Loktyushov E, Shulepko M, Koshelev S, Povarov I, Popov A, Peigneur S, Chugunov A, Kozlov S, Sharonova I, Efremov R, Skrebitsky V, Tytgat J, Kirpichnikov M, Lyukmanova E. Human Three-Finger Protein Lypd6 Is a Negative Modulator of the Cholinergic System in the Brain. Front Cell Dev Biol. 2021 Sep 21;9:662227. doi: 10.3389/fcell.2021.662227. eCollection 2021. PMID: 34631692; PMCID: PMC8494132.
Copy Download .nbib Format: NLM
Initial Experience with the Safe Implementation of Transanal Total Mesorectal Excision (TaTME) as a Standardized Procedure for Low Rectal Cancer.

Journal of clinical medicine

Dittrich L, Biebl M, Schmuck R, Gül S, Weiss S, Haase O, Knoop M, Alkatout I, Pratschke J, Aigner F.
PMID: 33379270
J Clin Med. 2020 Dec 28;10(1). doi: 10.3390/jcm10010072.

INTRODUCTION: The laparoscopic approach for TME is proven to be non-inferior in oncological outcome compared to open surgery. Anatomical limitations in the male and obese pelvis with resulting pathological shortcomings and high conversion rates were stimuli for alternative approaches....

Cite
Dittrich L, Biebl M, Schmuck R, et al. Initial Experience with the Safe Implementation of Transanal Total Mesorectal Excision (TaTME) as a Standardized Procedure for Low Rectal Cancer. J Clin Med. 2020;10(1)doi: 10.3390/jcm10010072.
Dittrich, L., Biebl, M., Schmuck, R., Gül, S., Weiss, S., Haase, O., Knoop, M., Alkatout, I., Pratschke, J., & Aigner, F. (2020). Initial Experience with the Safe Implementation of Transanal Total Mesorectal Excision (TaTME) as a Standardized Procedure for Low Rectal Cancer. Journal of clinical medicine, 10(1), . https://doi.org/10.3390/jcm10010072
Dittrich, Luca, et al. "Initial Experience with the Safe Implementation of Transanal Total Mesorectal Excision (TaTME) as a Standardized Procedure for Low Rectal Cancer." Journal of clinical medicine vol. 10,1 (2020). doi: https://doi.org/10.3390/jcm10010072
Dittrich L, Biebl M, Schmuck R, Gül S, Weiss S, Haase O, Knoop M, Alkatout I, Pratschke J, Aigner F. Initial Experience with the Safe Implementation of Transanal Total Mesorectal Excision (TaTME) as a Standardized Procedure for Low Rectal Cancer. J Clin Med. 2020 Dec 28;10(1). doi: 10.3390/jcm10010072. PMID: 33379270; PMCID: PMC7795301.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 117 entries